Valle William 4

What Happened
William Valle, a director of TriSalus Life Sciences, acquired 30,487 shares of TLSI on February 23, 2026. The shares were purchased at $4.10 each for a total transaction value of $124,997. This was a purchase (insider buy), which many investors view as a more informative signal than routine sales.

Key Details

• Transaction date: 2026-02-23
• Transaction type/code: Open-market purchase (P)
• Shares purchased: 30,487
• Price per share: $4.10
• Total value: $124,997
• Shares owned after transaction: Not disclosed in the provided filing details
• Footnotes/plans: No 10b5-1 plan, tax withholding, or other special footnotes reported in the supplied data
• Filing timeliness: No late-filing indication in the provided record

Context

• Purchases by directors represent direct cash commitment to the company; they are factual events (not proof of future performance).
• There is no indication this was part of an option exercise, gift, or tax withholding—this filing reports a straightforward purchase.